MINI FUTURE SHORT - AMGEN | Market Closed - Börse Stuttgart 20:43:20 27/06/2024 BST | ||
| 4.04 EUR | +2.28% |
|
| Current month | -16.14% | ||
| 1 month | -13.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 4.04 | +2.28% |
| 26/06/24 | 3.95 | +18.26% |
| 25/06/24 | 3.34 | -6.96% |
| 24/06/24 | 3.59 | -15.13% |
| 21/06/24 | 4.23 | -1.17% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 08:43 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
BNP Paribas
|
| WKN | PN6XGL |
| ISIN | DE000PN6XGL8 |
| Date issued | 08/08/2023 |
| Strike | 355.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.23 € |
|---|---|
| Lowest since issue | 2.85 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
